Gliclazide Modified-Release Metformin Hydrochloride Extended Release Tablets
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
What is Gliclazide MR + Metformin ER Used For?
- Gliclazide MR + Metformin ER is used for:
- Dual-Action Diabetes Control – Combines sulfonylurea and biguanide for comprehensive blood sugar management
- Improved Compliance – Modified/extended release allows once-daily dosing
- Insulin Secretion Enhancement – Stimulates the pancreas while improving insulin sensitivity
How Does Gliclazide MR + Metformin ER Work?
- This combination contains Gliclazide and Metformin in modified/extended release form, which:
- Gliclazide stimulates beta cells in the pancreas to release more insulin
- Metformin reduces glucose production by the liver and improves muscle insulin sensitivity
- Extended release provides 24-hour glucose control with reduced gastrointestinal side effects
How to Use Gliclazide MR + Metformin ER
Dosage: Take once daily as prescribed, usually at breakfast
Timing: Take with the first main meal of the day
Precaution: Monitor blood sugar regularly; hypoglycemia risk is higher; do not skip meals
Side Effects of Gliclazide MR + Metformin ER
Common Side Effects: Hypoglycemia, nausea, diarrhea, abdominal discomfort, metallic taste
Serious Side Effects (seek medical help): Severe hypoglycemia (confusion, seizures), lactic acidosis, allergic reactions, blood disorders
Benefits
- Dual mechanism: Gliclazide stimulates insulin secretion while Metformin improves insulin sensitivity
- Modified/extended release allows once-daily dosing for improved adherence
- Gliclazide MR has lower hypoglycemia risk than older sulfonylureas like glibenclamide
- Metformin component provides cardiovascular-neutral or beneficial metabolic effects
- Effective reduction in both fasting and post-meal glucose levels
- Lower GI side effects with the extended-release Metformin formulation
Warnings and Precautions
- Hypoglycemia risk — never skip meals; carry fast-acting glucose (tablets or juice)
- Avoid in severe renal impairment (eGFR <30), severe liver disease, or adrenal insufficiency
- Hold Metformin before iodinated contrast procedures; restart after kidney function confirmed
- Increased hypoglycemia risk in elderly, malnourished, or patients with irregular meal schedules
- Alcohol increases hypoglycemia risk — limit alcohol consumption
- Regular HbA1c monitoring every 3 months and periodic kidney function tests
Drug Interactions
- NSAIDs and aspirin: may potentiate hypoglycemic effect of Gliclazide
- Fluoroquinolone antibiotics: can disrupt blood sugar control; monitor closely
- Rifampicin, thiazide diuretics, corticosteroids: may reduce Gliclazide efficacy
- Alcohol: enhances hypoglycemia and may cause disulfiram-like reaction
- Cationic drugs (e.g., cimetidine): may increase Metformin levels
Storage Information
- Store at room temperature (15–25°C) away from moisture and heat
- Swallow tablets whole — do not crush; this destroys the modified-release mechanism
- Keep in original packaging until use
Frequently Asked Questions
Q1: What is Gliclazide MR + Metformin ER used for?
This combination treats type 2 diabetes using two mechanisms: Gliclazide stimulates insulin release while Metformin improves insulin sensitivity and reduces liver glucose production.
Q2: How does this combination lower blood sugar?
Gliclazide MR stimulates pancreatic beta cells to release more insulin. Metformin ER activates AMPK to reduce hepatic glucose output and enhance peripheral glucose uptake throughout the day.
Q3: When is the best time to take this combination?
Take once daily with the first main meal of the day (usually breakfast). This minimizes hypoglycemia risk and ensures adequate food is present.
Q4: What is the usual starting dose?
Dosing is individualized. Your doctor will select the appropriate Gliclazide dose (typically 30–60mg MR) combined with Metformin based on your current blood sugar levels.
Q5: Can this combination cause low blood sugar?
Yes. Gliclazide is a sulfonylurea that can cause hypoglycemia, especially if meals are skipped. Always eat regular meals and carry fast-acting glucose.
Q6: Can I take this combination with food?
Yes — take with your first main meal. Food is required to prevent hypoglycemia from the Gliclazide component. Do not take on an empty stomach.
Q7: What are the most common side effects?
Hypoglycemia, mild nausea, diarrhea, abdominal discomfort, and a metallic taste are common, especially when starting. GI effects are reduced with the extended-release formulation.
Q8: Is this combination safe for people with kidney disease?
Not recommended when eGFR is below 30 ml/min. Caution is needed between 30–45 ml/min. Regular kidney function monitoring is essential.
Q9: Can I take this during pregnancy?
No. Oral diabetes medications including sulfonylureas and Metformin are generally not recommended during pregnancy. Insulin is the standard of care. Consult your doctor.
Q10: How often should I check my blood sugar?
More frequent monitoring is needed with sulfonylurea-containing combinations, especially when starting or adjusting doses. HbA1c testing every 3 months.
Q11: How should I store this combination?
Store at room temperature (15–25°C) in original packaging, away from moisture. Swallow tablets whole — do not crush.
Q12: Do I need a prescription for this medication?
Yes, a prescription is required. A doctor will assess your diabetes control, kidney function, and hypoglycemia risk before prescribing.
Customer Reviews
Carol P.
Australia · 3 months ago
“Good service and genuine product. Glimepiride tablets came exactly as described. Delivery was prompt and packaging secure.”
Helen B.
UK · 2 weeks ago
“Dapagliflozin tablets are genuine. Packaging shows manufacturer details, lot number, and expiry. Reordering next month.”
Betty L.
USA · 6 weeks ago
“Managing diabetes requires consistent medication supply. Medionix has been fully dependable for 8 months of regular orders.”
Carol P.
Australia · 3 months ago
“Good service and genuine product. Glimepiride tablets came exactly as described. Delivery was prompt and packaging secure.”
Helen B.
UK · 2 weeks ago
“Dapagliflozin tablets are genuine. Packaging shows manufacturer details, lot number, and expiry. Reordering next month.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.